Skorpios Trust, Insider at Akero Therapeutics, Inc. (AKRO), sold 1,636,000 shares at $43.50 ($71.2M) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $71.2M AKRO by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.